journal article·2024-11

Hydrogel Derived from Decellularized Porcine Small Intestinal Submucosa as a Physical Shielding Repaired the Gut Epithelial Barrier of Murine Ulcerative Colitis

Hanxiao Pan, Bingyu Ding, Zhijiang Jiang, Jie Wang, Dingwei Li, Fengnan Yu, Lifen Wang, Sunkuan Hu, Yingzheng Zhao, Helin Xu

Advanced Functional Materials· Volume 34· Issue 45
Publisher page

Abstract

Abstract Ulcerative colitis (UC) is associated with the shedding of the gut mucus. Decellularized porcine small intestinal submucosa (SIS‐ECM) contains numerous active forms of extracellular matrix as well as growth factors. Herein, a mucus‐mimetic hydrogel (MAG) is designed as a barrier therapy by integrating SIS‐ECM with hyaluronic acid and epigallocatechin‐3‐gallate. MAG not only presented the viscoelastic behaviors with G' of 4000 Pa but also good thixotropy. Moreover, MAG as a physical shielding is effective to hinder E. coli invasion. Besides, the good repairing effect on the injured Caco‐2 cells is presented by MAG. When MAG as a biomimetic mucus is rectally administrated to colitis mouse, it alleviated effectively the colitis symptoms and improved the colonic shorting. Moreover, expression of IL‐1β, IL‐6, and TNF‐α at the laminae propria is substantially inhibited by MAG. Besides, the colonic epitheliums are well rearranged, and the tight junction proteins (ZO‐1, Occludin‐1, Claudin‐5) between them are greatly upregulated after MAG treatment. Meanwhile, the mucus secretion of goblets cells is effectively repaired by MAG treatment. The repairing mechanism of intestinal mucosa barriers is associated with promoting the proliferation and differentiation of intestinal stem cells. Collectively, MAG might be a promising strategy of barrier therapy for UC.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Clinical Nutrition and Gastroenterology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of pharmaceutics School of Pharmaceutical Sciences Wenzhou Medical University Wenzhou Zhejiang 325035 China

Cixi Biomedical Research Institute of Wenzhou Medical University CiXi Zhejiang 315302 China

Research Center for Drug Safety Evaluation Hainan Medical University Haikou Hainan 570216 China

Department of Gastroenterology the First Affiliated Hospital of Wenzhou Medical University Wenzhou Zhejiang 325000 China

Funding

Ningbo Municipal Bureau of Science and Technology · Wenzhou Municipal Science and Technology Bureau

References (54)

Show source-provided references
1. 10.1038/nrgastro.2015.15010.1038/nrgastro.2015.150 ↗
2. 10.3349/ymj.2021.62.2.9910.3349/ymj.2021.62.2.99 ↗
3. 10.3748/wjg.v23.i33.601610.3748/wjg.v23.i33.6016 ↗
4. Keane T. J. · J Crohns Colitis · 2017 · 11 · 360
5. 10.1038/s41575-022-00604-y10.1038/s41575-022-00604-y ↗
6. 10.1038/s41575-018-0003-z10.1038/s41575-018-0003-z ↗
7. 10.2174/13895575160315112612163310.2174/138955751603151126121633 ↗
8. 10.1136/gutjnl-2018-31690610.1136/gutjnl-2018-316906 ↗
9. 10.21037/tgh.2020.02.0210.21037/tgh.2020.02.02 ↗
10. 10.1039/D1TB00499A10.1039/D1TB00499A ↗
11. 10.1021/acsami.3c1568410.1021/acsami.3c15684 ↗
12. 10.1016/j.progpolymsci.2015.02.00410.1016/j.progpolymsci.2015.02.004 ↗
13. 10.1016/j.ymeth.2015.03.00510.1016/j.ymeth.2015.03.005 ↗
14. 10.1016/j.jcmgh.2017.09.00410.1016/j.jcmgh.2017.09.004 ↗
15. 10.3390/biomedicines1009221310.3390/biomedicines10092213 ↗
16. 10.3390/ijms2305282610.3390/ijms23052826 ↗
17. 10.1016/j.msec.2017.05.11810.1016/j.msec.2017.05.118 ↗
18. 10.1016/j.actbio.2016.11.06810.1016/j.actbio.2016.11.068 ↗
19. 10.1021/acsnano.2c0555810.1021/acsnano.2c05558 ↗
20. 10.1021/jacs.1c1354710.1021/jacs.1c13547 ↗
21. 10.1016/j.jconrel.2023.08.00710.1016/j.jconrel.2023.08.007 ↗
22. 10.1021/acsnano.7b0896910.1021/acsnano.7b08969 ↗
23. 10.1002/jbm.b.3310210.1002/jbm.b.33102 ↗
24. 10.3748/wjg.v22.i11.311710.3748/wjg.v22.i11.3117 ↗
25. 10.1016/j.biomaterials.2011.01.05710.1016/j.biomaterials.2011.01.057 ↗
26. 10.1016/j.actbio.2019.11.02910.1016/j.actbio.2019.11.029 ↗
27. 10.4012/dmj.2022-16710.4012/dmj.2022-167 ↗
28. 10.1021/acs.langmuir.2c0237210.1021/acs.langmuir.2c02372 ↗
29. 10.1016/j.ijbiomac.2023.12332310.1016/j.ijbiomac.2023.123323 ↗
30. 10.1136/gutjnl-2012-30320710.1136/gutjnl-2012-303207 ↗
31. 10.1038/ja.2016.4510.1038/ja.2016.45 ↗
32. 10.1021/acs.langmuir.9b0257210.1021/acs.langmuir.9b02572 ↗
33. 10.12968/jowc.2023.32.Sup1a.S1110.12968/jowc.2023.32.Sup1a.S11 ↗
34. 10.1038/mi.2017.5210.1038/mi.2017.52 ↗
35. 10.1111/jcmm.1334210.1111/jcmm.13342 ↗
36. 10.1136/gutjnl-2012-30424110.1136/gutjnl-2012-304241 ↗
37. 10.3389/fimmu.2021.67989710.3389/fimmu.2021.679897 ↗
38. 10.3390/ijms2203149110.3390/ijms22031491 ↗
39. 10.1038/s12276-023-00960-y10.1038/s12276-023-00960-y ↗
40. 10.1073/pnas.080312410510.1073/pnas.0803124105 ↗
41. 10.1126/sciadv.adh501610.1126/sciadv.adh5016 ↗
42. 10.3389/fmolb.2022.99605710.3389/fmolb.2022.996057 ↗
43. 10.1016/j.drudis.2022.05.02210.1016/j.drudis.2022.05.022 ↗
44. 10.1016/j.biopha.2020.11093710.1016/j.biopha.2020.110937 ↗
45. 10.2147/JIR.S35880710.2147/JIR.S358807 ↗
46. 10.1007/s00253-021-11453-110.1007/s00253-021-11453-1 ↗
47. 10.1128/Spectrum.00730-2110.1128/Spectrum.00730-21 ↗
48. 10.1016/j.biomaterials.2009.06.04510.1016/j.biomaterials.2009.06.045 ↗
49. 10.1016/j.actbio.2022.02.03910.1016/j.actbio.2022.02.039 ↗
50. 10.1002/ame2.1206710.1002/ame2.12067 ↗
51. 10.1038/s41401-021-00781-710.1038/s41401-021-00781-7 ↗
52. 10.1038/nprot.2007.4110.1038/nprot.2007.41 ↗
53. Cooper H. S. · Lab Invest · 1993 · 69 · 238
54. 10.1021/acs.jafc.6b0380610.1021/acs.jafc.6b03806 ↗